FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Real-time BOERSE MUENCHEN 12:25:51 2024-05-21 pm EDT | ||
| 11.74 EUR | -1.18% |
|
| Current month | +7.80% | ||
| 1 month | +12.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 11.74 | -1.18% |
| 24-05-20 | 11.88 | -0.17% |
| 24-05-17 | 11.9 | +1.71% |
| 24-05-16 | 11.7 | -1.35% |
| 24-05-15 | 11.86 | +1.54% |
Real-time BOERSE MUENCHEN
Last update May 21, 2024 at 12:25 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG33J9 |
| ISIN | DE000GG33J99 |
| Date issued | 2024-02-12 |
| Strike | 511.8 p |
| Maturity | Unlimited |
| Parity | 0.51 : 1 |
| Emission price | 13.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.27 € |
|---|---|
| Lowest since issue | 10.4 € |
| Spread | 0.1 € |
| Spread % | 0.84% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13
USD
Average target price
16.36
USD
Spread / Average Target
+25.88%
- Stock Market
- Certificates
- Certificat
